Influenza vaccine (ADImmune)

流感病毒裂解疫苗（国光生物）

Report date: 2022/10/17 17:01:17

Base Information

Drug NameInfluenza vaccine (ADImmune)
Drug Alias Name裂解型流感疫苗（国光生物）Seasonal influenza virus vaccine - AdimmuneAdimflu-S Children季节性流感疫苗（国光生物）安定伏 +[6] 
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryTaiwan
Original Approved Date2015/01/01
Country/TerritoryBelgiumTaiwanItaly +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAdimmune Corp
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Clover Biopharmaceuticals IncAdimmune Corp
Inactive CompaniesSimoon Record Pharma Information Consulting Co LtdBeijing Feituosi Pharmaceutical Technology Co LtdUniversity Of Oxford +[5] 
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A